Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Telethonin is a small protein localized to the Z-disc of striated muscle, encoded by the TCAP gene on chromosome 17. It regulates the assembly and stability of sarcomeres—the contractile units of muscle—and interacts with titin and other sarcomeric proteins to maintain muscle fiber structure. Telethonin is essential for proper muscle development, function, and adaptation, and its activity can be modulated by phosphorylation via several kinases. Dysfunction due to TCAP mutations causes LGMD2G, marked by early onset skeletal muscle weakness, scapular winging, and calf hypertrophy. Telethonin has also been implicated in various cardiomyopathies and can modulate cell death pathways, indicating wider functions in muscle physiology and disease.
For investigational therapies, gene replacement delivers functional copies of TCAP to restore normal telethonin protein production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Telethonin (TCAP).